Lista de obras -

4th Pediatric Allergy and Asthma Meeting (PAAM)

artículo científico publicado en 2016

6th International Symposium on Molecular Allergology (ISMA).

artículo científico publicado en 2016

A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens

artículo científico publicado en 2019

Abstracts from the 11th Symposium on Experimental Rhinology and Immunology of the Nose (SERIN 2017).

artículo científico publicado en 2017

Clinical validation of a house dust mite environmental challenge chamber model

artículo científico publicado en 2017

Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitis.

artículo científico publicado en 2014

Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life

artículo científico publicado en 2016

Exposure to a farming environment has allergen-specific protective effects on TH2-dependent isotype switching in response to common inhalants

article

Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy

artículo científico publicado en 2012

Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen

artículo científico publicado en 2016

Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing properties

artículo científico publicado en 2010

Prevention of allergic asthma through Der p 2 peptide vaccination.

artículo científico publicado en 2015

Ragweed Pollen Allergy: Burden, Characteristics, and Management of an Imported Allergen Source in Europe

artículo científico publicado en 2018

Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering.

artículo científico publicado en 2008

Reliable mite-specific IgE testing in nasal secretions by means of allergen microarray

artículo científico publicado en 2017

Selection of house dust mite-allergic patients by molecular diagnosis may enhance success of specific immunotherapy

scientific article published on 14 November 2018

Underestimation of house dust mite-specific IgE with extract-based ImmunoCAPs compared with molecular ImmunoCAPs

scientific article published on 27 July 2018

Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts

artículo científico publicado en 2012

Lista de obras de

4th Pediatric Allergy and Asthma Meeting (PAAM)

6th International Symposium on Molecular Allergology (ISMA).

A hypoallergenic peptide mix containing T cell epitopes of the clinically relevant house dust mite allergens

Abstracts from the 11th Symposium on Experimental Rhinology and Immunology of the Nose (SERIN 2017).

Clinical validation of a house dust mite environmental challenge chamber model

Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitis.

Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life

Exposure to a farming environment has allergen-specific protective effects on TH2-dependent isotype switching in response to common inhalants

Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy

Molecular, Structural and Immunological Characterization of Der p 18, a Chitinase-Like House Dust Mite Allergen

Phl p 5 resorption in human oral mucosa leads to dose-dependent and time-dependent allergen binding by oral mucosal Langerhans cells, attenuates their maturation, and enhances their migratory and TGF-beta1 and IL-10-producing properties

Prevention of allergic asthma through Der p 2 peptide vaccination.

Ragweed Pollen Allergy: Burden, Characteristics, and Management of an Imported Allergen Source in Europe

Reduction of the in vivo allergenicity of Der p 2, the major house-dust mite allergen, by genetic engineering.

Reliable mite-specific IgE testing in nasal secretions by means of allergen microarray

Selection of house dust mite-allergic patients by molecular diagnosis may enhance success of specific immunotherapy

Underestimation of house dust mite-specific IgE with extract-based ImmunoCAPs compared with molecular ImmunoCAPs

Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts